health

Uxin Announces Entry into Definitive Agreements for Financing

BEIJING,March 5,2025-- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN),China\'s leading used car retailer,today announced that,it entered into certain definitive agreements w

This is Wuhan: a journey through time

WUHAN,China,March 5,2025-- A report fromChangjiang Daily. This is Wuhan: a journey through time Recently,"Traveling in China" has become a highly trending topic on social media platforms,as

Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

HONG KONG,March 6,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical tria

USHOPAL Expands Global Luxury Beauty Portfolio with the Acquisition of French Skincare Icon PAYOT

SHANGHAI,March 4,2025-- USHOPAL Group continues to solidify its position as the first China-based luxury beauty group to emerge on the global stage,with an acquisition strategy that focuses on strong

GTS Techlabs and Peacom Announce Strategic Partnership to Transform Business Messaging at MWC Barcelona 2025

BARCELONA,Spain,March 5,2025-- GTS Techlabs,the technology arm ofGlobe Teleservices (GTS),a leading telecom solutioncompany,and Peacom have announced a strategic partnership at Mobile World Congress

Prenetics Announces Fourth Quarter and Full Year 2024 Financial Results, Provides 2025 Guidance

Revenue grew 93.5% to $10.5 million in the fourth quarter and 40.9% year-over-year to $30.6 million in 2024

Global Industry Partners Jointly Release Net5.5G Best Practices & Deployment Guide Whitepaper

BARCELONA,Spain,March 5,2025-- At MWC Barcelona 2025,the Broadband Development Congress (BDC),hosted by the WBBA,was a resounding success. Themed "Smarter Broadband: Investment. Innovation. Intel

CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL

PhaseIb trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL),aiming to reshape the standard-of-care landscape.

Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma

HONG KONG,March 6,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical tria

A New University Science Park of Neusoft Institute Guangdong to Foster Innovation in Cross-sector Development

HONG KONG,March 1,2025-- Neusoft Institute Guangdong,a member of Neutech Group Limited,has successfully acquired the land use rights for a new 140,000-square-meter plot in Nanhai District,Foshan City,

Home 1 2 3 4 Next Tail

10 Items Per Page (Page 1 / 82) Total 817 Items

©copyright 2009-2020 Mlada frontadnes      Contact Us   SiteMap